Abstract 6080: Preferential tumor uptake and retention of EGL-001, an anti-CTLA4 -IL2 mutein fusion antibody achieving selective tumor Treg depletion
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Fundación Ciencia and Vida
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409629524
